6Kanis JA,Johnell O, Oden A, et al. Ten year probabilities of oteoporotie fractures according to BMD and diagnostie thresholds[J]. Osteoporosis International, 2001,12 (10) : 989-995.
7Dennis MB, Desmond ET, Douglas C, et al. Fracture risk reduction with a lendronate in women with osteoporosis: the fracture intervention trial[J]. The Journal of Clinical Endocrinology & Metabolism,2000,85(11) :4118-4124.
8Takata J, Iba K, Imoto K, et al. Changes in bone resorption markers among Japanese patients with postmenopausal osteoporosis treated with alendronate and risedronate[J]. J Bone Miner Metab, 2007, 25(2) :142-146.
9Hanley DA,Josse RG.Prevention and management of osteoporosis:consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada:1.Introduction[J].CMAJ,1996; 155(7):921-923.
10Mundy G,Garrett R,Harris S,Chan J,Chen D,Rossini G,Boyce B,Zhao M,Gutierrez G.Stimulation of bone formation in vitro and in rodents by statins[J].Science,1999; 286(3):1946-1349.
